Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Introduction To Survival Analysis01:18

Introduction To Survival Analysis

932
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
932
Survival Tree01:19

Survival Tree

464
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
464
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

697
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
697
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

5.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.9K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

2.7K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.7K
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

691
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
691

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

C-Peptide Provides Critical Contextual Insight Into Elevated Glucose Values During Progression to Type 1 Diabetes.

Diabetes care·2026
Same author

Impact of Body Size on Preclinical Type 1 Diabetes Development and Progression.

Diabetes care·2026
Same author

Assessing Time Below Range as a Predictor of Severe Hypoglycemia: Insights From Six Clinical Trials.

Diabetes care·2026
Same author

Baseline Serum Metabolites as Predictors of Teplizumab Response in Individuals with Type 1 Diabetes.

medRxiv : the preprint server for health sciences·2026
Same author

Too soon to grow: linking gut health to early puberty onset.

Pediatric research·2025
Same author

Baseline Insulin Secretion Determines Response to Abatacept in Stage 1 Type 1 Diabetes.

Diabetes·2025

Related Experiment Video

Updated: Mar 21, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

17.4K

Predicting the Timing of the Metabolic Inflection Point in Type 1 Diabetes Progression Using Machine Learning and

Eslam Montaser1, Jay M Sosenko2, Heba M Ismail3

  • 1Division of Endocrinology and Metabolism, Indiana University School of Medicine, Indianapolis, IN.

Diabetes
|March 20, 2026
PubMed
Summary
This summary is machine-generated.

Machine learning models can now predict the metabolic inflection point (IP) preceding type 1 diabetes in autoantibody-positive individuals up to 1.4 years before diagnosis using dynamic oral glucose tolerance test data.

More Related Videos

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

750
Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
10:03

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

2.4K

Related Experiment Videos

Last Updated: Mar 21, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

17.4K
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

750
Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
10:03

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

2.4K

Area of Science:

  • Metabolic disease research
  • Computational biology
  • Clinical diagnostics

Background:

  • Type 1 diabetes (T1D) onset is preceded by a metabolic inflection point (IP).
  • Early identification of the IP is crucial for timely intervention in autoantibody-positive individuals.
  • Current methods lack precision in predicting the timing of the IP.

Purpose of the Study:

  • To develop and validate machine learning (ML) models for early detection of the metabolic IP.
  • To utilize dynamic features from oral glucose tolerance tests (OGTT) for IP proximity detection.
  • To enable personalized risk stratification for T1D development.

Main Methods:

  • Support vector machine (SVM) model trained on TrialNet Pathway to Prevention data.
  • Validation of the SVM model using Diabetes Prevention Trial-Type 1 data.
  • Application of a Cox proportional hazards model for time-to-IP estimation.

Main Results:

  • The SVM model achieved an area under the curve (AUC) of 0.77 for predicting IP at 1.4 years pre-diagnosis.
  • Models demonstrated strong calibration and interpretability.
  • Cox model provided complementary numeric estimates of time to IP.

Conclusions:

  • ML models using OGTT-derived dynamic features can significantly improve early identification of the metabolic IP.
  • These findings support earlier intervention strategies and personalized monitoring for individuals at risk of T1D.
  • OGTT-based risk stratification offers a novel approach for proactive diabetes management.